1. Jaffe ES, Harris NL, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissue. France: IARC Press, Lyon;2001. p. 150–1. p. 152–4.
2. Castoldi G, Piva N, Tomasi P. Multiple myeloma with Auer-rodlike inclusions. Haematologica. 1999; 84:859–60.
3. Metzgeroth G, Back W, Maywald O, Schatz M, Willer A, Hehlmann R, et al. Auer rod-like inclusions in multiple myeloma. Ann Hematol. 2003; 82:57–60.
Article
4. Raman SB, Van Slyck EJ. Nature of intracytoplasmic crystalline inclusions in myeloma cells (morphologic, cytochemical, ultrastructural, and immunofluorescent studies). Am J Clin Pathol. 1983; 80:224–8.
Article
5. Casciaro S, Clavio M, Boccaccio P. Unusual intracellular and extracellular crystal inclusions in light chain multiple myeloma. Haematologica. 1999; 84:1046–7.
6. VM, Meenu Bal M, Varma N, Sakhuja V. Auer rod-like inclusions in immunoglobulin a multiple myeloma. Arch Pathol Lab Med. 2005; 129:706–7.
7. Grossniklaus HE, Stulting RD, L'Hernault N. Corneal and conjunctival crystals in paraproteinemia. Hum Pathol. 1990; 21:1181–3.
Article
8. Messiaen T, Deret S, Mougenot B, Bridoux F, Dequiedt P, Dion JJ, et al. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine. 2000; 79:135–54.
9. Jung JY, Park CJ, Cho HC, Park YS. Intranuclear inclusion in IgG-lambda multiple myeloma. Korean J Clin Pathol. 1996; 16:139–42.
10. Ko GA, Park CJ, Cho HC. A case of intracytoplasmic crystalline inclusions in multiple myeloma with Fanconi syndrome. Korean J Clin Pathol. 1996; 16:143–6.
11. Greipp PR, Leong T, Bennett JM, Gaillard JP, Klein B, Stewart JA, et al. Plasmablastic morphology–an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group. Blood. 1998; 91:2501–7.
Article
12. Gardais J, Genevieve F, Foussard C, Delisle V, Zandecki M. Is there any significance for intracellular crystals in plasma cells from patients with monoclonal gammopathies? Eur J Haematol. 2001; 67:119–22.
Article
13. Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001; 12:1482–92.
Article
14. Pozzi C, D'Amico M, Fogazzi GB, Curioni S, Ferrario F, Pasquali S, et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis. 2003; 42:1154–63.
Article
15. Lacy MQ, Gertz MA. Acquired Fanconi's syndrome associated with monoclonal gammopathies. Hematol Oncol Clin North Am. 1999; 13:1273–80.
Article
16. Lajoie G, Leung R, Bargman JM. Clinical, biochemical, and pathological features in a patient with plasma cell dyscrasia and Fanconi syndrome. Ultrastruct Pathol. 2000; 24:221–6.
Article
17. Gu X, Barrios R, Cartwright J, Font RL, Truong L, Herrera GA. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy. Hum Pathol. 2003; 34:270–7.
Article
18. Asplin JR, Coe FL. Tubular disorders. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 16th ed.New York: McGraw-Hill;2004. p. 1694–702.
19. Deret S, Denoroy L, Lamarine M, Vidal R, Mougenot B, Frangione B, et al. Kappa light chain-associated Fanconi's syndrome molecular analysis of monoclonal immunoglobulin light chains from patients with and without intracellular crystals. Protein Eng. 1999; 12:363–9.
20. Aucouturier P, Bauwens M, Khamlichi AA, Denoroy L, Spinelli S, Touchard G, et al. Monoclonal IgL chain and L chain V domain gragment crystallization in myeloma-associated Fanconi's syndrome. J Immunol. 1993; 150:3561–8.